Literature DB >> 7650198

Genotypic detection of Mycobacterium tuberculosis rifampin resistance: comparison of single-strand conformation polymorphism and dideoxy fingerprinting.

T A Felmlee1, Q Liu, A C Whelen, D Williams, S S Sommer, D H Persing.   

Abstract

Detection of mutations in the rpoB gene of Mycobacterium tuberculosis can be used as an accurate predictor of rifampin resistance in the majority of strains tested. Simple but highly accurate screening methods must be developed for the detection of these mutations. Either DNA sequence analysis or single-strand conformation polymorphism (SSCP) screening can be used to detect rpoB mutations, but these techniques either are expensive or yield results that may prove difficult to interpret when used in a clinical setting. This report describes the use of dideoxy fingerprinting (ddF) as a postamplification screening method to identify rifampin-resistant genotypes. The ddF protocol was performed on the amplified rpoB fragment with no preparatory steps, thus making ddF practical for laboratories equipped for polyacrylamide gel electrophoresis. When compared with the results of SSCP analysis, ddF results were more easily interpreted and contained more sequence-dependent information that facilitated differentiation of functionally significant and silent mutations. The ddF method was used for genotypic determination of rifampin susceptibility of 20 multidrug-resistant strains of M. tuberculosis. The results of this analysis were concordant with DNA sequence analysis and conventional clinical laboratory methods.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7650198      PMCID: PMC228227          DOI: 10.1128/jcm.33.6.1617-1623.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Dideoxy fingerprinting (ddE): a rapid and efficient screen for the presence of mutations.

Authors:  G Sarkar; H S Yoon; S S Sommer
Journal:  Genomics       Date:  1992-06       Impact factor: 5.736

2.  Preventing false positives: quantitative evaluation of three protocols for inactivation of polymerase chain reaction amplification products.

Authors:  P N Rys; D H Persing
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

3.  Detection of a genetic locus encoding resistance to rifampin in mycobacterial cultures and in clinical specimens.

Authors:  J M Hunt; G D Roberts; L Stockman; T A Felmlee; D H Persing
Journal:  Diagn Microbiol Infect Dis       Date:  1994-04       Impact factor: 2.803

4.  Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis.

Authors:  A Telenti; P Imboden; F Marchesi; D Lowrie; S Cole; M J Colston; L Matter; K Schopfer; T Bodmer
Journal:  Lancet       Date:  1993-03-13       Impact factor: 79.321

5.  Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas.

Authors:  V Kapur; L L Li; S Iordanescu; M R Hamrick; A Wanger; B N Kreiswirth; J M Musser
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

6.  Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance.

Authors:  D J Jin; C A Gross
Journal:  J Mol Biol       Date:  1988-07-05       Impact factor: 5.469

7.  Nationwide survey of drug-resistant tuberculosis in the United States.

Authors:  A B Bloch; G M Cauthen; I M Onorato; K G Dansbury; G D Kelly; C R Driver; D E Snider
Journal:  JAMA       Date:  1994-03-02       Impact factor: 56.272

8.  Direct, automated detection of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reaction and single-strand conformation polymorphism analysis.

Authors:  A Telenti; P Imboden; F Marchesi; T Schmidheini; T Bodmer
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

9.  Characterization of rifampin-resistance in pathogenic mycobacteria.

Authors:  D L Williams; C Waguespack; K Eisenach; J T Crawford; F Portaels; M Salfinger; C M Nolan; C Abe; V Sticht-Groh; T P Gillis
Journal:  Antimicrob Agents Chemother       Date:  1994-10       Impact factor: 5.191

10.  Parameters affecting the sensitivities of dideoxy fingerprinting and SSCP.

Authors:  Q Liu; S S Sommer
Journal:  PCR Methods Appl       Date:  1994-10
View more
  27 in total

1.  Detection of rifampin resistance in Mycobacterium tuberculosis by double gradient-denaturing gradient gel electrophoresis.

Authors:  P Scarpellini; S Braglia; P Carrera; M Cedri; P Cichero; A Colombo; R Crucianelli; A Gori; M Ferrari; A Lazzarin
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

2.  Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from Brazil.

Authors:  A R Valim; M L Rossetti; M O Ribeiro; A Zaha
Journal:  J Clin Microbiol       Date:  2000-08       Impact factor: 5.948

Review 3.  Molecular detection of antimicrobial resistance.

Authors:  A C Fluit; M R Visser; F J Schmitz
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 4.  Genetic methods for assessing antimicrobial resistance.

Authors:  F R Cockerill
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

5.  Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City.

Authors:  R C Cooksey; G P Morlock; S Glickman; J T Crawford
Journal:  J Clin Microbiol       Date:  1997-05       Impact factor: 5.948

6.  Genotypic detection of mutations in rifampicin resistant clinical isolates ofMycobacterium tuberculosis.

Authors:  L M Srivastava; M Khanna; A Goel; R C Jain
Journal:  Indian J Clin Biochem       Date:  1997-12

7.  New real-time PCR able to detect in a single tube multiple rifampin resistance mutations and high-level isoniazid resistance mutations in Mycobacterium tuberculosis.

Authors:  Darío García de Viedma; Maria del Sol Díaz Infantes; Fátima Lasala; Fernando Chaves; Luis Alcalá; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

Review 8.  Relevance of nucleic acid amplification techniques for diagnosis of respiratory tract infections in the clinical laboratory.

Authors:  M Ieven; H Goossens
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

9.  Rapid detection of rpoB gene mutations in rifampin-resistant Mycobacterium tuberculosis isolates in shanghai by using the amplification refractory mutation system.

Authors:  Xiao-Yong Fan; Zhong-Yi Hu; Fan-Hong Xu; Zhi-Qiang Yan; Sheng-Qi Guo; Zhong-Ming Li
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

10.  Peptide nucleic acid-mediated competitive PCR clamping for detection of rifampin-resistant Mycobacterium tuberculosis.

Authors:  Tomotada Iwamoto; Toshiaki Sonobe
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.